The FCF Life Sciences Venture Capital Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies, displaying Venture capital financing trends in the European Life Sciences industry.
LIFE SCIENCES RESEARCH SERIES
We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:
Venture Capital Monitor
Monthly Venture capital activities in the European Life Sciences sector
Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Public Equity MonitorRecent valuations of listed European Life Sciences companies
IPO ReportRecent IPO trends in the Life Sciences sector
NEWS & PRESS
FCF Life Sciences co-organizes “ACCESS CHINA Forum – Winter Online Partnering Weeks”
FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Forum – Winter Online Partnering Weeks” which will be held online on January 4th-22nd, 2021. ACCESS CHINA is the most effective deal-making platform for
FCF Life Sciences Venture Capital Monitor – 10/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 10/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Fox Corporate Finance GmbH advises Immunic on financing the development of a potential COVID-19 drug
Gräfelfing/Munich, October 23rd, 2020 – FCF Fox Corporate Finance acts as advisor to Immunic, a biotechnology company specialized on immunology therapies, in the execution of a venture loan financing with the European Investment Bank (EIB).
FCF Life Sciences Venture Capital Monitor – 08/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 08/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Life Sciences Venture Capital Monitor – 09/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 09/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
